Search details
1.
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
Clin Pharmacol Ther
; 71(1): 57-67, 2002 Jan.
Article
in English
| MEDLINE | ID: mdl-11823758
2.
Pros and cons of therapeutic drug monitoring of antiretroviral agents.
Curr Opin Infect Dis
; 15(1): 17-22, 2002 Feb.
Article
in English
| MEDLINE | ID: mdl-11964901
3.
Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance.
Ther Drug Monit
; 24(5): 579-87, 2002 Oct.
Article
in English
| MEDLINE | ID: mdl-12352928
4.
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.
J Acquir Immune Defic Syndr
; 30(3): 324-34, 2002 Jul 01.
Article
in English
| MEDLINE | ID: mdl-12131570
5.
Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations.
Ther Drug Monit
; 25(1): 73-80, 2003 Feb.
Article
in English
| MEDLINE | ID: mdl-12548148
6.
Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?
J Acquir Immune Defic Syndr
; 29(1): 101-2, 2002 Jan 01.
Article
in English
| MEDLINE | ID: mdl-11782597
Results
1 -
6
de 6
1
Next >
>>